These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18328232)

  • 1. Mineral trioxide aggregate as a pulpotomy medicament: a narrative review.
    Ng FK; Messer LB
    Eur Arch Paediatr Dent; 2008 Mar; 9(1):4-11. PubMed ID: 18328232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Glenny AM; Courson F; Durieux P; Muller-Bolla M; Fron Chabouis H
    Cochrane Database Syst Rev; 2018 May; 5(5):CD003220. PubMed ID: 29852056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.
    Noorollahian H
    Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study.
    Naik S; Hegde AH
    J Indian Soc Pedod Prev Dent; 2005 Mar; 23(1):13-6. PubMed ID: 15858300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineral trioxide aggregate as a pulpotomy medicament: an evidence-based assessment.
    Ng FK; Messer LB
    Eur Arch Paediatr Dent; 2008 Jun; 9(2):58-73. PubMed ID: 18534173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Courson F; Durieux P; Muller-Bolla M; Glenny AM; Fron Chabouis H
    Cochrane Database Syst Rev; 2014 Aug; (8):CD003220. PubMed ID: 25099759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol.
    Stringhini Junior E; Vitcel ME; Oliveira LB
    Eur Arch Paediatr Dent; 2015 Aug; 16(4):303-12. PubMed ID: 25833280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there sufficient evidence to support the long-term efficacy of mineral trioxide aggregate (MTA) for endodontic therapy in primary teeth?
    Anthonappa RP; King NM; Martens LC
    Int Endod J; 2013 Mar; 46(3):198-204. PubMed ID: 23136828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of MTA pulpotomy in primary molars: a critical assessment of relevant studies.
    Elkhadem A; Nagi P
    Evid Based Dent; 2013; 14(2):46. PubMed ID: 23792397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6- to 24-month observation.
    Sushynski JM; Zealand CM; Botero TM; Boynton JR; Majewski RF; Shelburne CE; Hu JC
    Pediatr Dent; 2012; 34(5):120-8. PubMed ID: 23211896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D; Jayanthi M
    Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary molar pulpotomy: a systematic review and network meta-analysis.
    Lin PY; Chen HS; Wang YH; Tu YK
    J Dent; 2014 Sep; 42(9):1060-77. PubMed ID: 24513112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineral trioxide aggregate material use in endodontic treatment: a review of the literature.
    Roberts HW; Toth JM; Berzins DW; Charlton DG
    Dent Mater; 2008 Feb; 24(2):149-64. PubMed ID: 17586038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy.
    Saltzman B; Sigal M; Clokie C; Rukavina J; Titley K; Kulkarni GV
    Int J Paediatr Dent; 2005 Nov; 15(6):437-47. PubMed ID: 16238654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Success of mineral trioxide aggregate in pulpotomized primary molars.
    Farsi N; Alamoudi N; Balto K; Mushayt A
    J Clin Pediatr Dent; 2005; 29(4):307-11. PubMed ID: 16161395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on methodological problems of 'Is there sufficient evidence to support the long-term efficacy of mineral trioxide aggregate for endodontic therapy in primary teeth?' by Anthonappa R P et al. (International Endodontic Journal, 46, 198-204, 2013).
    Asgary S; Shirvani A
    Int Endod J; 2014 Jun; 47(6):611-2. PubMed ID: 24138297
    [No Abstract]   [Full Text] [Related]  

  • 17. Mineral trioxide aggregate pulpotomies: a case series outcomes assessment.
    Witherspoon DE; Small JC; Harris GZ
    J Am Dent Assoc; 2006 May; 137(5):610-8. PubMed ID: 16739540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth.
    Agamy HA; Bakry NS; Mounir MM; Avery DR
    Pediatr Dent; 2004; 26(4):302-9. PubMed ID: 15344622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTA and ferric sulfate in pulpotomy outcomes of primary molars: a systematic review and meta-analysis.
    Asgary S; Shirvani A; Fazlyab M
    J Clin Pediatr Dent; 2014; 39(1):1-8. PubMed ID: 25631717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAT of the month. Mineral trioxide aggregate (MTA) successful for pulpotomy treatment (UT CAT #2296).
    Alsalman Z; Philip J; Norling B
    Tex Dent J; 2012 Oct; 129(10):1074. PubMed ID: 23311027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.